Rafael Mikolajczyk
- Modeling and Simulation top 0.1%
- COVID-19 epidemiological studies 24
- Hepatology top 0.5%
- Epidemiology top 0.2%
- Substance Abuse Treatment and Outcomes 15
- Hepatitis B Virus Studies 14
- Obstetrics and Gynecology top 0.5%
- Health top 0.5%
- Vaccine Coverage and Hesitancy 19
-
- COVID-19 and Mental Health 21
-
- Health and Medical Studies 16
-
- Long-Term Effects of COVID-19 14
-
- Behavioral Health and Interventions 13
- Co-authors
- Johannes HornGérard KrauseJördis J. OttAparna SchweitzerWalid El AnsariAnnette E. MaxwellManas K. AkmatovMirjam Kretzschmar
- Journals
- The Lancet (2 papers)Nature Communications (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Rafael Mikolajczyk
286 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 198
- Modeling and Simulation 1.7k
- Hepatology 1.8k
- Epidemiology 4.5k
- Obstetrics and Gynecology 1.0k
- Health 1.0k
Countries citing papers authored by Rafael Mikolajczyk
This map shows the geographic impact of Rafael Mikolajczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Mikolajczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Mikolajczyk more than expected).
Fields of papers citing papers by Rafael Mikolajczyk
This network shows the impact of papers produced by Rafael Mikolajczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Mikolajczyk. The network helps show where Rafael Mikolajczyk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rafael Mikolajczyk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 4 | |
| 10 | 2022 | 0 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 10 | |
| 13 | 2020 | 20 | |
| 14 | 2020 | 9 | |
| 15 | 2020 | 30 | |
| 16 | 2018 | 6 | |
| 17 | 2017 | 56 | |
| 18 | Illicit substance use among university students from seven European countries: A comparison of personal and perceived peer use and personal and perceived peer attitudes towards illicit substance use | 2014 | 1 |
| 19 | 2014 | 43 | |
| 20 | Determinants of neonatal and under-three mortality in Central Asian countries: Kyrgyzstan, Kazakhstan and Uzbekistan | 2006 | 5 |
About Rafael Mikolajczyk
Rafael Mikolajczyk is a scholar working on Applied Microbiology and Biotechnology, Modeling and Simulation and Health, having authored 310 papers that have together received 11.3k indexed citations. Recurring topics across this work include COVID-19 epidemiological studies (24 papers), COVID-19 and Mental Health (21 papers), Vaccine Coverage and Hesitancy (19 papers), Health and Medical Studies (16 papers), Substance Abuse Treatment and Outcomes (15 papers), Hepatitis B Virus Studies (14 papers), Long-Term Effects of COVID-19 (14 papers) and Behavioral Health and Interventions (13 papers). The work is most often cited by research in Modeling and Simulation (1.7k citations), Hepatology (1.8k citations) and Epidemiology (4.5k citations). Rafael Mikolajczyk has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Johannes Horn, Gérard Krause, Jördis J. Ott, Aparna Schweitzer, Walid El Ansari, Annette E. Maxwell, Manas K. Akmatov, Mirjam Kretzschmar, Christiane Stock and Jacco Wallinga. Their work appears in journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.